Vendor Business Qualification

Vendor Qualification Inefficiencies

Large pharmaceutical companies face significant challenges in vendor business qualification, particularly when managing vendors across clinical and non-clinical operations. Disjointed systems and manual processes dominate the qualification landscape, requiring serial steps that often take 4-6 months to complete. Information is fragmented across multiple departments, making data collection labor-intensive and prone to errors. This lack of integration and visibility across studies, therapeutic areas, subsidiaries, and business units further complicates the process, leading to inefficiencies and delays. Additionally, the absence of centralized data management results in duplicate systems and redundant efforts, consuming valuable time and resources. Without automated alerts for key events, such as contract expirations or requalification deadlines, pharma companies also risk non-compliance and missed opportunities to address low-performing vendors. These inefficiencies increase operational costs, delay trial timelines, and jeopardize quality, making vendor qualification a persistent and critical challenge for large pharmaceutical organizations.

VISION Centralizes Qualification Processes

Strategikon’s VISION solution transforms vendor qualification processes by providing a centralized, streamlined platform. VISION acts as a single source of truth, eliminating disjointed systems and manual processes. With automated workflows for setting up qualification surveys, evaluating performance, and scoring risks, VISION reduces manual activities by over 90%, ensuring faster and more accurate data collection. The platform integrates vendor information across all departments, studies, and business units, offering complete visibility and transparency. Automated alerts for contract expiration, requalification deadlines, and performance issues ensure proactive vendor oversight. Additionally, VISION supports compliance and risk reduction, delivering a more structured and reliable qualification process. As a SaaS-based solution, VISION eliminates duplicate systems and lowers maintenance costs, significantly reducing the internal effort required to manage vendors centrally.

Time, Cost, and Risk Reductions

Pharma companies using VISION experience substantial time and cost savings, with over 75% reductions in vendor qualification costs and internal effort. Processes that once took months now take days, allowing for faster project starts and improved operational efficiency. The platform’s centralized data hub enhances visibility across all vendor activities, ensuring consistent qualification standards and streamlined oversight. VISION also significantly mitigates compliance risks through its alert system, reducing vendor-related risks by over 95%. These improvements lead to higher quality in vendor management and better allocation of resources.

Streamlined Vendor Management with VISION

Large pharmaceutical companies can overcome the challenges of vendor qualification with Strategikon’s VISION solution. By centralizing data, automating processes, and enhancing compliance tracking, VISION reduces inefficiencies and risks while accelerating vendor qualification timelines. The result is a streamlined, cost-effective approach that ensures consistent standards, improves collaboration, and supports successful clinical and non-clinical operations. VISION empowers pharma companies to focus on innovation and strategic goals rather than being bogged down by operational complexities.